TY - JOUR AU - Jemal, A. AU - Siegel, R. AU - Xu, J. AU - Ward, E. PY - 2010 DA - 2010// TI - Cancer statistics, 2010 JO - CA Cancer J Clin VL - 60 UR - https://doi.org/10.3322/caac.20073 DO - 10.3322/caac.20073 ID - Jemal2010 ER - TY - JOUR AU - Jacobs, B. L. AU - Lee, C. T. AU - Montie, J. E. PY - 2010 DA - 2010// TI - Bladder cancer in 2010: how far have we come? JO - CA Cancer J Clin VL - 60 UR - https://doi.org/10.3322/caac.20077 DO - 10.3322/caac.20077 ID - Jacobs2010 ER - TY - STD TI - Elias K, Svatek RS, Gupta S, Ho R, Lotan Y: High-risk patients with hematuria are not evaluated according to guideline recommendations. Cancer. 116 (12): 2954-2959. ID - ref3 ER - TY - STD TI - Youssef RF, Schlomer BJ, Ho R, Sagalowsky AI, Ashfaq R, Lotan Y: Role of fluorescence in situ hybridization in bladder cancer surveillance of patients with negative cytology. Urol Oncol. ID - ref4 ER - TY - JOUR AU - Lotan, Y. AU - Roehrborn, C. G. PY - 2002 DA - 2002// TI - Cost-effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the followup of patients with transitional cell carcinoma of the bladder: a decision analytical approach JO - J Urol VL - 167 UR - https://doi.org/10.1016/S0022-5347(05)65386-4 DO - 10.1016/S0022-5347(05)65386-4 ID - Lotan2002 ER - TY - JOUR AU - Vrooman, O. P. AU - Witjes, J. A. PY - 2009 DA - 2009// TI - Molecular markers for detection, surveillance and prognostication of bladder cancer JO - Int J Urol VL - 16 UR - https://doi.org/10.1111/j.1442-2042.2008.02225.x DO - 10.1111/j.1442-2042.2008.02225.x ID - Vrooman2009 ER - TY - STD TI - Horstmann M, Bontrup H, Hennenlotter J, Taeger D, Weber A, Pesch B, Feil G, Patschan O, Johnen G, Stenzl A, et al: Clinical experience with survivin as a biomarker for urothelial bladder cancer. World J Urol. 28 (3): 399-404. ID - ref7 ER - TY - JOUR AU - Smith, S. D. AU - Wheeler, M. A. AU - Plescia, J. AU - Colberg, J. W. AU - Weiss, R. M. AU - Altieri, D. C. PY - 2001 DA - 2001// TI - Urine detection of survivin and diagnosis of bladder cancer JO - JAMA VL - 285 UR - https://doi.org/10.1001/jama.285.3.324 DO - 10.1001/jama.285.3.324 ID - Smith2001 ER - TY - JOUR AU - Zhu, Z. B. AU - Makhija, S. K. AU - Lu, B. AU - Wang, M. AU - Kaliberova, L. AU - Liu, B. AU - Rivera, A. A. AU - Nettelbeck, D. M. AU - Mahasreshti, P. J. AU - Leath, C. A. PY - 2004 DA - 2004// TI - Transcriptional targeting of tumors with a novel tumor-specific survivin promoter JO - Cancer Gene Ther VL - 11 UR - https://doi.org/10.1038/sj.cgt.7700679 DO - 10.1038/sj.cgt.7700679 ID - Zhu2004 ER - TY - JOUR AU - Rossi, M. R. AU - Masters, J. R. AU - Park, S. AU - Todd, J. H. AU - Garrett, S. H. AU - Sens, M. A. AU - Somji, S. AU - Nath, J. AU - Sens, D. A. PY - 2001 DA - 2001// TI - The immortalized UROtsa cell line as a potential cell culture model of human urothelium JO - Environ Health Perspect VL - 109 UR - https://doi.org/10.1289/ehp.01109801 DO - 10.1289/ehp.01109801 ID - Rossi2001 ER - TY - JOUR AU - Hoffman, W. H. AU - Biade, S. AU - Zilfou, J. T. AU - Chen, J. AU - Murphy, M. PY - 2002 DA - 2002// TI - Transcriptional repression of the anti-apoptotic survivin gene by wild type p53 JO - J Biol Chem VL - 277 UR - https://doi.org/10.1074/jbc.M106643200 DO - 10.1074/jbc.M106643200 ID - Hoffman2002 ER - TY - JOUR AU - Luo, J. AU - Deng, Z. L. AU - Luo, X. AU - Tang, N. AU - Song, W. X. AU - Chen, J. AU - Sharff, K. A. AU - Luu, H. H. AU - Haydon, R. C. AU - Kinzler, K. W. PY - 2007 DA - 2007// TI - A protocol for rapid generation of recombinant adenoviruses using the AdEasy system JO - Nat Protoc VL - 2 UR - https://doi.org/10.1038/nprot.2007.135 DO - 10.1038/nprot.2007.135 ID - Luo2007 ER - TY - JOUR AU - Kulkarni, G. S. AU - Alibhai, S. M. AU - Finelli, A. AU - Fleshner, N. E. AU - Jewett, M. A. AU - Lopushinsky, S. R. AU - Bayoumi, A. M. PY - 2009 DA - 2009// TI - Cost-effectiveness analysis of immediate radical cystectomy versus intravesical Bacillus Calmette-Guerin therapy for high-risk, high-grade (T1G3) bladder cancer JO - Cancer VL - 115 UR - https://doi.org/10.1002/cncr.24634 DO - 10.1002/cncr.24634 ID - Kulkarni2009 ER - TY - CHAP AU - Mitra, A. P. ED - Kumar, G. L. ED - Kiernan, J. A. PY - 2010 DA - 2010// TI - Urine cytologic analysis: special techniques for bladder cancer detection BT - Connection ID - Mitra2010 ER - TY - STD TI - Zuiverloon TC, van der Aa MN, van der Kwast TH, Steyerberg EW, Lingsma HF, Bangma CH, Zwarthoff EC: Fibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade non-muscle-invasive bladder cancer. Clin Cancer Res. 16 (11): 3011-3018. ID - ref15 ER - TY - STD TI - Jacobs BL, Lee CT, Montie JE: Bladder Cancer in 2010: How Far have We Come?. CA Cancer J Clin. ID - ref16 ER - TY - JOUR AU - Belik, R. AU - Follmann, W. AU - Degen, G. H. AU - Roos, P. H. AU - Blaszkewicz, M. AU - Knopf, H. J. AU - Golka, K. PY - 2008 DA - 2008// TI - Improvements in culturing exfoliated urothelial cells in vitro from human urine JO - J Toxicol Environ Health A VL - 71 UR - https://doi.org/10.1080/15287390801988871 DO - 10.1080/15287390801988871 ID - Belik2008 ER - TY - JOUR AU - Okuno, H. AU - Kakehi, Y. AU - Ozdemir, E. AU - Terachi, T. AU - Okada, Y. AU - Yoshida, O. PY - 1997 DA - 1997// TI - Association of in vitro growth potential of urinary exfoliated cells with tumor localization and intraluminal recurrence rates of urothelial cancers JO - J Urol VL - 158 UR - https://doi.org/10.1016/S0022-5347(01)64200-9 DO - 10.1016/S0022-5347(01)64200-9 ID - Okuno1997 ER - TY - JOUR AU - Van Houdt, W. J. AU - Haviv, Y. S. AU - Lu, B. AU - Wang, M. AU - Rivera, A. A. AU - Ulasov, I. V. AU - Lamfers, M. L. AU - Rein, D. AU - Lesniak, M. S. AU - Siegal, G. P. PY - 2006 DA - 2006// TI - The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma JO - J Neurosurg VL - 104 UR - https://doi.org/10.3171/jns.2006.104.4.583 DO - 10.3171/jns.2006.104.4.583 ID - Van Houdt2006 ER - TY - JOUR AU - Ulasov, I. V. AU - Tyler, M. A. AU - Zhu, Z. B. AU - Han, Y. AU - He, T. C. AU - Lesniak, M. S. PY - 2009 DA - 2009// TI - Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy JO - Int J Oncol VL - 34 ID - Ulasov2009 ER - TY - JOUR AU - Moussa, O. AU - Abol-Enein, H. AU - Bissada, N. K. AU - Keane, T. AU - Ghoneim, M. A. AU - Watson, D. K. PY - 2006 DA - 2006// TI - Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer JO - J Urol VL - 175 UR - https://doi.org/10.1016/S0022-5347(06)00254-0 DO - 10.1016/S0022-5347(06)00254-0 ID - Moussa2006 ER - TY - JOUR AU - Altieri, D. C. PY - 2004 DA - 2004// TI - Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm JO - J Cell Biochem VL - 92 UR - https://doi.org/10.1002/jcb.20140 DO - 10.1002/jcb.20140 ID - Altieri2004 ER - TY - JOUR AU - Ryan, B. AU - O'Donovan, N. AU - Browne, B. AU - O'Shea, C. AU - Crown, J. AU - Hill, A. D. AU - McDermott, E. AU - O'Higgins, N. AU - Duffy, M. J. PY - 2005 DA - 2005// TI - Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer JO - Br J Cancer VL - 92 UR - https://doi.org/10.1038/sj.bjc.6602314 DO - 10.1038/sj.bjc.6602314 ID - Ryan2005 ER - TY - JOUR AU - Weikert, S. AU - Schrader, M. AU - Krause, H. AU - Schulze, W. AU - Muller, M. AU - Miller, K. PY - 2005 DA - 2005// TI - The inhibitor of apoptosis (IAP) survivin is expressed in human testicular germ cell tumors and normal testes JO - Cancer Lett VL - 223 UR - https://doi.org/10.1016/j.canlet.2004.10.038 DO - 10.1016/j.canlet.2004.10.038 ID - Weikert2005 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/11/168/prepub UR - http://www.biomedcentral.com/1471-2407/11/168/prepub ID - ref25 ER -